Showing 51-60 of 352 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Insulin dose and vascular complications in T1D: its role beyond insulin resistance and glycemia | University of Pittsburgh | Rachel Miller | Improving Lives | 01-July-2026 to 30-June-2029 | $749.947,12 |
| Localized delivery of costimulatory inhibitors and tolerogenic stromal cells for targeted immunomodulation in beta cell replacement | University of Miami | Alice Tomei | Cures | 01-February-2024 to 31-January-2027 | $824.892,00 |
| Nano-encapsulated microparticulate drug delivery platforms for decreasing islet graft immunogenicity | University of Miami | Dhanashree Surve | Cures | 01-March-2026 to 28-February-2029 | $274.010,00 |
| The KQ1 serum study: amendment & extension | University of Miami | Dirk Homann | Cures | 01-April-2025 to 31-October-2027 | $1.723.254,07 |
| Towards an integrated proteomic and transcriptomic single-cell atlas of the human pancreas | University of Miami | Dirk Homann | Cures | 01-April-2025 to 31-March-2027 | $53.972,92 |
| Safety, Feasibility, and Mechanistic Effects of Diroximel Fumarate (DRF) in New-Onset Type 1 Diabetes. | University of Miami | Francesco Vendrame | Cures | 01-August-2026 to 31-July-2029 | $698.164,00 |
| Preclinical development of the BMP receptor agonist THR-184 for beta cell regeneration | University of Miami | Juan Dominguez-Bendala | Cures | 01-April-2024 to 31-March-2027 | $741.000,00 |
| Role of pericytes during type 1 diabetes pathogenesis | University of Miami | Luciana Mateus Goncalves | Cures | 01-March-2024 to 28-February-2027 | $259.750,00 |
| bifunctional RNA therapeutics for T1D | University of Miami | Paolo Serafini | Cures | 01-February-2025 to 31-January-2028 | $900.000,00 |
| Modulate beta cell proliferation and immunogenicity via aptamer-decorated lipid nanoparticles | University of Miami | Paolo Serafini | Cures | 01-April-2023 to 31-March-2027 | $894.602,00 |